These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23948629)

  • 1. Neural response to emotional stimuli associated with successful antidepressant treatment and behavioral activation.
    Rizvi SJ; Salomons TV; Konarski JZ; Downar J; Giacobbe P; McIntyre RS; Kennedy SH
    J Affect Disord; 2013 Nov; 151(2):573-581. PubMed ID: 23948629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study.
    Robertson B; Wang L; Diaz MT; Aiello M; Gersing K; Beyer J; Mukundan S; McCarthy G; Doraiswamy PM
    J Clin Psychiatry; 2007 Feb; 68(2):261-7. PubMed ID: 17335325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Default mode network deactivation during emotion processing predicts early antidepressant response.
    Spies M; Kraus C; Geissberger N; Auer B; Klöbl M; Tik M; Stürkat IL; Hahn A; Woletz M; Pfabigan DM; Kasper S; Lamm C; Windischberger C; Lanzenberger R
    Transl Psychiatry; 2017 Jan; 7(1):e1008. PubMed ID: 28117844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
    Taneja C; Papakostas GI; Jing Y; Baker RA; Forbes RA; Oster G
    Ann Pharmacother; 2012 May; 46(5):642-9. PubMed ID: 22550279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of olanzapine/fluoxetine combination vs fluoxetine monotherapy following successful combination therapy of treatment-resistant major depressive disorder.
    Brunner E; Tohen M; Osuntokun O; Landry J; Thase ME
    Neuropsychopharmacology; 2014 Oct; 39(11):2549-59. PubMed ID: 24801768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients.
    Farabaugh A; Mischoulon D; Fava M; Wu SL; Mascarini A; Tossani E; Alpert JE
    Int Clin Psychopharmacol; 2005 Mar; 20(2):87-91. PubMed ID: 15729083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.
    Kennedy SE; Koeppe RA; Young EA; Zubieta JK
    Arch Gen Psychiatry; 2006 Nov; 63(11):1199-208. PubMed ID: 17088500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
    Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
    Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
    Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
    J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Brain Entropy as a predictor of antidepressant response in major depressive disorder.
    Liu X; Song D; Yin Y; Xie C; Zhang H; Zhang H; Zhang Z; Wang Z; Yuan Y
    J Affect Disord; 2020 Jan; 260():716-721. PubMed ID: 31563070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early improvement in HAMD-17 and HAMD-6 scores predicts ultimate response and remission for depressed patients treated with fluoxetine or ECT.
    Lin HS; Lin CH
    J Affect Disord; 2019 Feb; 245():91-97. PubMed ID: 30368075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder.
    Victor TA; Furey ML; Fromm SJ; Öhman A; Drevets WC
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2195-208. PubMed ID: 23809145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features.
    Rothschild AJ; Williamson DJ; Tohen MF; Schatzberg A; Andersen SW; Van Campen LE; Sanger TM; Tollefson GD
    J Clin Psychopharmacol; 2004 Aug; 24(4):365-73. PubMed ID: 15232326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy.
    Walsh ND; Williams SC; Brammer MJ; Bullmore ET; Kim J; Suckling J; Mitterschiffthaler MT; Cleare AJ; Pich EM; Mehta MA; Fu CH
    Biol Psychiatry; 2007 Dec; 62(11):1236-43. PubMed ID: 17601497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder.
    Hung YY; Lin CC; Kang HY; Huang TL
    Brain Behav Immun; 2017 Jan; 59():265-272. PubMed ID: 27640899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. fMRI response to negative words and SSRI treatment outcome in major depressive disorder: a preliminary study.
    Miller JM; Schneck N; Siegle GJ; Chen Y; Ogden RT; Kikuchi T; Oquendo MA; Mann JJ; Parsey RV
    Psychiatry Res; 2013 Dec; 214(3):296-305. PubMed ID: 24446548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors related to the improvement in quality of life for depressed inpatients treated with fluoxetine.
    Yang WC; Lin CH; Wang FC; Lu MJ
    BMC Psychiatry; 2017 Aug; 17(1):309. PubMed ID: 28841824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an antidepressant on neural correlates of emotional processing in patients with major depression.
    Wang Y; Xu C; Cao X; Gao Q; Li J; Liu Z; Sun N; Ren Y; Zhang K
    Neurosci Lett; 2012 Oct; 527(1):55-9. PubMed ID: 22954751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report.
    van Dinteren R; Arns M; Kenemans L; Jongsma ML; Kessels RP; Fitzgerald P; Fallahpour K; Debattista C; Gordon E; Williams LM
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):1981-90. PubMed ID: 26282359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.